|
New Asthma Drug Generates Excitement For Patients — And Its Maker
Forbes An experimental asthma drug could give new hope to patients for whom existing medicines are not enough and give yet another boost to Regeneron Pharmaceuticals, the company developing it, which has seen its shares rise 376% in the past two years, … Regeneron, Sanofi asthma drug seen as potential game changer Monoclonal antibody appears effective and safe in asthma Phase IIa trial Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In … |
View full post on asthma – Google News